Skip to main content
HRB Open Research logoLink to HRB Open Research
. 2026 Oct 20;9:63. Originally published 2026 Jun 16. [Version 3] doi: 10.12688/hrbopenres.14446.3

Fear Of cancer Recurrence Group-based intervEntion (FORGE): Study protocol for the co-design of a psychological intervention for young adult cancer survivors

Catherine O'Brien 1,2,a, Maria Pertl 3, Emer Guinan 1, Andrew Darley 4, Suzanne Guerin 5, Sonya Collier 2, Maeve Lowery 1,2
PMCID: PMC13680839  PMID: 42922490

Version Changes

Revised. Amendments from Version 2

In this revised version, we made a number of updates in response to the peer reviewer’s feedback. In the Methods section, the intervention core components have been added. An amendment has been made to the inclusion criteria to include a proposed recruitment matrix.

Abstract

Background

Fear of cancer recurrence (FCR) represents one of the most frequently reported unmet needs among cancer survivors, with young adults demonstrating heightened susceptibility to its effects. Although a range of specialist-delivered psychological interventions has shown efficacy in managing FCR across adult populations, much of this evidence is derived from one-to-one therapeutic formats. Adapting such interventions to a group setting, both to enhance peer support and to improve resource efficiency, necessitates careful adaptation to ensure the programme is appropriately tailored to the group context. The aim of this study is to co-design the adaptation of an existing one-to-one FCR psychological intervention to a group-based setting to support psychosocial distress across the spectrum of FCR needs of young adult cancer survivors in Ireland.

Methods

This co-design study will use the ADAPT framework to conduct a series of workshops that adopt a modified Nominal Group Technique (NGT) model. Two groups of co-design stakeholders will be recruited nationally (i) Experts by Experience (Cancer survivors and family caregivers); (ii) Experts by Profession (e.g., doctors, nurses, psychologists). Three individual workshops with representatives from both groups will be held in different locations across Ireland. A consensus workshop will be held online to collate results via a voting system and establish the design of an adapted group-based FCR intervention. The workshops will be co-facilitated by the lead researcher, a Patient and Public Involvement (PPI) partner and a member of the project steering committee.

Discussion

Group-based interventions offer an efficient way to deliver targeted FCR support for young adult cancer survivors, while providing peer connection. The adapted peer-co-designed group-based FCR intervention will subsequently undergo feasibility evaluation to determine its acceptability and potential for broader implementation across Irish cancer centres.

Keywords: Fear of Cancer Recurrence, Co-design, Group-based intervention, Public and Patient Involvement, Psychological intervention, Cancer survivor

Introduction

Fear of cancer recurrence (FCR) is one of the most common unmet needs among cancer survivors, with approximately 59% reporting at least moderate levels of FCR and close to one in five patients experiencing high or clinically significant levels. 1– 4 This is pointedly higher for younger adult patients (84%) for a number of reasons, including their likely long survival rates and risk of developing secondary malignancies. 5 Early-onset cancer in young adults under 50 years has increased over the past two decades, creating distinct physical, psychosocial and support needs. 6, 7 Their experience is often socially isolating and marked by significant distress and uncertainty with attainment of life milestones such as education, career, relationships and family considerably impacted by FCR. 6, 8, 9 This highlights the growing need to tailor age-specific psychological support groups with peers of similar age. 9, 10

The effectiveness and efficacy of various psychological interventions for FCR have been widely demonstrated, particularly in a one-to-one format. FCR psychological interventions need to be accessible and efficient to meet the needs of the growing population of people living with and beyond cancer, with growing healthcare costs and limited resources. 11 Group-based approaches are more scalable, can maximise resources and provide peer support. 12, 13 While adapting evidence-based interventions for new contexts is regarded as more efficient than developing entirely new approaches, their effectiveness may diminish when they are replicated without modification. 14 Wide variation in existing group-based FCR programmes limits evidence on optimal design, highlighting the need for further research on how best to adapt one-to-one FCR interventions for different clinical settings, particularly for young adult cancer survivors.

Adapting existing interventions, in order to work in practice, need to be co-designed with both professional and PPI stakeholders to ensure they are based on the lived experiences of individuals living with and beyond cancer. 15 The focus of patient and public involvement (PPI) in clinical research has become increasingly essential in the past decade to ensure meaningful outcomes by empowering patients and the public to play an active role in their healthcare decisions and facilitate shared decision-making. 16 This study will use the ADAPT framework and co-design to adapt an existing contemporary FCR intervention, currently delivered in a one-to-one format, into a group setting for cancer survivors at a large comprehensive cancer centre in Ireland. 14, 17 The intervention is grounded in the theoretical framework of Acceptance and Commitment Therapy (ACT), incorporating core ACT processes to support psychological flexibility and behaviour change. 11, 18– 20 An initial feasibility study undertaken within the hospital suggested a strong interest in a group-based FCR intervention, highlighting the need for high-quality empirical research. 21 This study will focus on the design and delivery aspects that are imperative for the adaptation and implementation of intervention, appropriately tailored to the needs of young adult cancer survivors.

Aims

To co-design the adaptation of a group-based intervention that is feasible and appropriate for young adult patients (aged 18–50 years) with at least moderate levels of FCR-related distress.

Objectives

  • •

    To collaborate with people living with and beyond cancer, family caregivers and health professionals, in adapting an existing contemporary one-to-one FCR intervention to a group-based format that is age-specific.

  • •

    To ensure the logistics of the design are based on the lived experiences of individuals living with and beyond cancer through stakeholder partnership, while maintaining the core components of the psychological intervention, to ensure accessibility, uptake and sustained engagement.

  • •

    To co-design an appropriate management intervention for psychosocial distress across the spectrum of FCR needs, which are scalable and transferrable to psycho-oncology multidisciplinary teams recently established in other cancer centres nationally, and will be sustainable as a survivorship-friendly intervention.

Methods

ADAPT framework

This study is part of a larger project that aims to adapt and test an existing one-to-one FCR psychological intervention into a group setting. Table 1 outlines the steps in the ADAPT framework with details relating to this study. 14 This phase follows step 2 in the process.

Table 1. ADAPT framework for FORGE study.

ADAPT step Key activities
Step 1 Assess the rationale for intervention, and consider intervention-context fit
  • •
    Conducted a prevalence survey with the target population to identify different FCR levels (N = 394)
  • •
    Conducted a scoping review on existing programmes
  • •
    Selected the FCR psychological intervention for adaptation
Step 2 Plan and undertake adaptations
  • •
    Establish an adaptation team (steering committee) comprising stakeholders with diverse expertise
  • •
    Conduct co-design workshops with participants reflective of target population
  • •
    Collate data from co-design workshops for intervention adaptation
Step 3 Plan and undertake piloting and evaluation
  • •
    Plan to undertake feasibility pilot study
  • •
    Evaluate adapted group-based intervention through survey and questionnaires
Step 4 Implement and maintain the adapted intervention at scale
  • •
    N/A as this is a feasibility pilot study

Intervention core components

The intervention selected for adaptation is an existing ACT-informed FCR programme currently delivered on an individual basis, for cancer survivors at a large comprehensive cancer centre in Ireland. The programme includes several evidence-based CBT components, including psychoeducation, cognitive restructuring, mindfulness, and worry management techniques ( Table 2). To maintain intervention fidelity, the therapeutic content and underlying behaviour change elements will remain unchanged throughout the co-design process. Instead, the co-design activities will focus on implementation and delivery considerations, including session logistics, group composition, and venue preferences. Participants will be informed that the intervention framework comprises a minimum of two hours of content delivered across two sessions, within which they can contribute to the design and optimisation of the programme’s format and delivery.

Table 2. Core Components of existing FCR Intervention.

Core Component
1. Psychoeducation about FCR
2. Cognitive restructuring
3. Worry management
4. Acceptance of uncertainty
5. Values clarification
6. Choice point decision making
7. Mindfulness and grounding

Patient and Public Involvement (PPI)

A PPI panel comprising three experts with lived experience of cancer and aged between 18–50 years, informed the development of this protocol. This process included the development of participant information leaflets, research questions, and practical considerations for the workshops. The PPI partners will co-facilitate the co-design workshops to create an open and supportive environment, enhance credibility and ensure more meaningful and participant-centred discussion. They are members of the project steering committee, together with representatives from psychology, nursing, medicine and relevant academic fields. The committee will inform and shape the overall project decision-making by drawing on their knowledge, experience and expertise to ensure the project achieves the intended outcomes and impact. The PPI panel contribution will be reported using the short form Guidance for Reporting Involvement of Patients and the Public (GRIPP2-SF). 16

Co-design participants

This study will use the principles of co-design through stakeholder consultation to conduct three workshops with a minimum of ten participants recruited for each workshop. 22, 23 Participants will be Experts by Experience (Cancer survivors and family caregivers) and Experts by Profession (e.g., doctors, nurses, psychologists) to adapt an existing contemporary one-to-one FCR intervention, currently delivered in a large comprehensive cancer centre in Ireland, into the group-based format.

The workshops will be promoted via social media, patient cancer advocacy groups, and healthcare professional networks. All cancer types and healthcare professions will be encouraged to participate. Interested individuals can contact the lead researcher to ask questions about the study and receive the Participant Information Leaflet by post or email, or access the leaflet through a QR code on the poster. Written consent will be obtained in person at the workshop.

Inclusion criteria

Cancer survivors ( Experts by Experience)

  • •

    Received a diagnosis of any cancer type and completed active cancer treatment at least one year previously (i.e. surgery, radiotherapy, chemotherapy).

  • •

    Aged between 18 and 50 years.

  • •

    Have experienced Fear of Cancer Recurrence or have a specific interest in the topic.

  • •

    Be able to provide informed written consent.

  • •

    Be fluent in English language.

Family Caregiver Representatives ( Experts by Experience)

  • •

    Be the family caregiver for someone who has completed active cancer treatment at least one year previously who were aged between 18 and 50 years at time of cancer treatment completion.

  • •

    Be the family caregiver for someone who has experienced Fear of Cancer Recurrence or have a specific interest in the topic.

  • •

    Be able to provide informed written consent.

  • •

    Be fluent in English language.

Healthcare Professionals ( Experts by Profession)

  • •

    Medical, nursing, psychologist, social worker, physiotherapist, occupational therapist or other healthcare professional working and involved in the care of patients, aged between 18 and 50 years, living with and beyond cancer.

  • •

    Be able to provide informed written consent.

  • •

    Be fluent in English language.

Exclusion criteria

Cancer survivor/Family Caregiver Representatives

  • •

    Cancer patients with evidence of disease recurrence or metastases.

  • •

    Caring for someone with evidence of disease recurrence or metastases.

  • •

    Unable to provide informed consent.

  • •

    Not fluent in English language.

Healthcare Professionals

  • •

    Not working with cancer patients.

Table 3 outlines the proposed recruitment matrix.

Table 3. Proposed recruitment matrix.

Characteristic Cancer Survivors Family Caregivers Healthcare Professionals
Stakeholder group Individuals with lived experience of cancer Individuals with lived experience of supporting a family member with cancer Professionals involved in cancer survivorship care
Age at treatment completion Representation across 18–30, 31–40 and 41–50 years where feasible Caring for survivors diagnosed/treated between 18–50 years Professionals caring for adults aged 18–50 years
Sex/Gender Diverse representation where possible Diverse representation where possible Diverse representation where possible
Cancer type Range of cancer diagnoses where feasible Experience supporting different cancer diagnoses Experience caring for patients with varied cancer diagnoses
Time since treatment completion 1–2 years, 3–5 years, >5 years Caring experience relating to different survivorship stages Varying years of professional experience
Geographic location Urban and rural settings Urban and rural settings Hospital and community settings where applicable
Previous experience of FCR Range of FCR experiences and concerns Experience supporting FCR concerns in a family member Experience with cancer survivors in clinical practice
Professional/educational background Diverse occupational backgrounds Diverse occupational backgrounds Nursing, medicine, psychology, social work, physiotherapy, occupational therapy, and other relevant disciplines

Study procedures

This study will use a modified Nominal Group Technique (NGT) through a series of workshops. NGT is a highly structured, face-to-face group intervention that poses specific questions for discussion, empowering participants by giving them an opportunity to have their voices and opinions heard by all members. 24 The group workshop is highly structured and involves two to three questions which are sent to the participants in advance:

  • 1.

    What would be the most effective way to deliver the group-based programme? (i.e., number/frequency/length of sessions)

  • 2.

    What age groups/cancers would be best together at the group-based programme? (i.e., specific age groups/mixture of ages, different/same cancers)

  • 3.

    What would be the preferred venue for the group-based programme? (i.e., hospital/cancer support centre, virtual)

The NGT method is highly adaptive, and variations can be influenced by a number of factors, including consensus or generalisability required for the topic. 25 Typically, NGTs involve a single workshop; however, in this study, there will be three individual face-to-face workshops held in different geographically located areas to ensure broad national representation, encompassing both rural and urban areas in Ireland. Participants will be invited to attend one workshop to discuss the first three steps (i.e. idea generation, sharing ideas, and refining ideas). Each workshop will follow the same format posing the same questions to each group. The final step of ranking and voting on ideas to reach consensus will be held virtually, with participants from all three workshops invited to participate. 26

While NGTs typically range from two to fourteen participants, a maximum of seven has been recommended. 25 It is anticipated there will be a minimum of ten participants recruited in this study for each of the three workshops – six to seven cancer survivors/family carer representatives ( Experts by Experience) and three to four healthcare professionals ( Experts by Profession). This approach is to ensure that the different participant age ranges (18–50 years) are represented and allows for a variety of healthcare professional representation. This number will also allow for attrition while ensuring representation of each cohort. Each workshop will be facilitated by the lead researcher and a member of the steering committee, including a PPI partner.

Following an introduction to the study and purpose of the workshop by the lead researcher, participants will be divided into subgroups of three or four with a mix of Experts by Experience and Experts by Profession in each group. This approach is a modification to the NGT structure to combine steps one and two (‘idea generation’ and ‘sharing of ideas’) to allow for the larger group structure and time constraints, while ensuring each participant has an opportunity to contribute. 25 Each subgroup will be facilitated by a member of the research team. The lead researcher will explain the discussion question and allow 30–40 minutes for each subgroup to generate suggestions. Post-it notepads will be used to colour code answers from each question. A final discussion will take place with the whole group to clarify and refine the ideas generated.

All participants from each of these three workshops will then be invited to attend a virtual stakeholder meeting to complete the final stage of the co-design process- ‘ranking/voting preference of ideas’. The ideas generated from the three workshops will be compiled and presented to the group. The number of votes for each idea will be added up to reach a final consensus. Results will be available in real time, with participants seeing them for each question. 27

Data collection

Participants will provide demographic details at the beginning of the face-to-face workshops to outline representation from both Experts by Experience and Experts by Profession. The workshops will not be recorded but written post-it notes generated during the workshops will be secured by the lead researcher.

Results

Data analysis

Summative content analysis will be used to categorise the ideas generated during the three face-to-face workshops. This method allows the identification of recurring keywords to detect the most common suggestions for each question. Voting responses at the online virtual consensus meeting will be captured using the Mentimeter poll, a third-party platform specialising in online interactive voting and ranking. 28, 29 Results will be automatically populated onto an Excel spreadsheet highlighting the weight and ranking preferences for each question and will be available to participants at the end of the consensus meeting.

Discussion

Group-based interventions offer a structured and efficient approach to delivering targeted FCR treatments while fostering a peer support environment. However, variations in current group design highlight the need for further work to adapt an existing contemporary group-based FCR intervention that will address the needs of young adult cancer survivors experiencing at least moderate levels of FCR in Ireland. The outcome of this study will provide the structure for a psychological intervention that has been created by peers who have experienced the same condition and collaborated on its design. The next phase of the overall project (ADAPT Step 3) will involve a feasibility pilot to assess the suitability and acceptability of the adapted, scalable group-based FCR intervention for use across cancer centres in Ireland.

Ethical approval

This research has been approved by SJH/TUH Joint Research Ethics Committee (St James’s Hospital/Tallaght Hospital) on 6 th May 2025, Project ID 4347. Written Informed consent will be obtained by all participants.

Acknowledgments

Co-design team - Aoibhin Golden, David Holland and Lorraine White for the commitment and engagement in their contribution to the study design and conduct as members of the steering committee.

Funding Statement

This work was funded by the Irish Cancer Society through the research grant CNRA23OBR.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

[version 3; peer review: 1 approved, 2 approved with reservations]

Data availability

Underlying data

No data are associated with this article.

References

  • 1. Luigjes-Huizer YL, Lee ML, Richel C, et al. : Patient-reported needs for coping with worry or fear about cancer recurrence and the extent to which they are being met: a survey study. J. Cancer Surviv. 2024;18(3):791–799. 10.1007/s11764-022-01326-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Luigjes-Huizer YL, Tauber NM, Humphris G, et al. : What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psycho-Oncology. 2022;31(6):879–892. 10.1002/pon.5921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Adashek JJ, Jordan A, Redwine LS, et al. : Pan-cancer analysis of fear of cancer recurrence among cancer survivors. ESMO Open. 2022;7(4):100528. 10.1016/j.esmoop.2022.100528 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Herschbach P, Berg P, Waadt S, et al. : Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother. Psychosom. 2010;79(1):31–38. 10.2307/48511235 [DOI] [PubMed] [Google Scholar]
  • 5. Lane BE, Garland SN, Chalifour K, et al. : Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer. J. Cancer Surviv. 2019;13(6):842–851. 10.1007/s11764-019-00802-9 [DOI] [PubMed] [Google Scholar]
  • 6. Hamilton AC, Donnelly DW, Fitzpatrick D, et al. : Early-onset cancers in adults: a review of epidemiology, supportive care needs and future research priorities. Cancer. 2022;14(16):4021. 10.3390/cancers14164021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Ugai T, Sasamoto N, Lee H-Y, et al. : Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat. Rev. Clin. Oncol. 2022;19(10):656–673. 10.1038/s41571-022-00672-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Avutu V, Lynch KA, Barnett ME, et al. : Psychosocial needs and preferences for care among adolescent and young adult cancer patients (ages 15–39): a qualitative study. Cancer. 2022;14(3):710. 10.3390/cancers14030710 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Vitaloni M, Maguet K, Carlan A, et al. : Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. BMC Gastroenterol. 2025;25(1):378. 10.1186/s12876-025-03976-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Sansom-Daly UM, Wakefield CE, Ellis SJ, et al. : Online, Group-Based Psychological Support for Adolescent and Young Adult Cancer Survivors: Results from the Recapture Life Randomized Trial. Cancers (Basel). 2021;13(10). 10.3390/cancers13102460 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Tauber NM, O’Toole MS, Jensen AB, et al. : ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors. Psychooncology. 2023;32(9):1424–1432. 10.1002/pon.6193 [DOI] [PubMed] [Google Scholar]
  • 12. Lebel S, Zwaal C, Craig L, et al. : Fear of cancer recurrence guideline. Program in Evidence-Based Care Guideline. 2024(19–7).
  • 13. Tauber NM, Zachariae R, Jensen AB, et al. : ConquerFear-group: Feasibility study with pilot results of a psychological intervention for fear of cancer recurrence delivered in groups. Psychooncology. 2022;31(1):30–38. 10.1002/pon.5772 [DOI] [PubMed] [Google Scholar]
  • 14. Moore G, Campbell M, Copeland L, et al. : Adapting interventions to new contexts—the ADAPT guidance. BMJ. 2021;374:374. 10.1136/bmj.n1679 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kiss N, Jongebloed H, Baguley B, et al. : Meaningful consumer involvement in cancer care: a systematic review on co-design methods and processes. JNCI Cancer Spectrum. 2024;8. 10.1093/jncics/pkae048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Vanneste A, Wens I, Sinnaeve P, et al. : Evolution of reported patient and public involvement over time in randomised controlled trials in major medical journals and in their protocols: meta-epidemiological evaluation. BMJ. 2025;389:e082697. 10.1136/bmj-2024-082697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. O’Brien J, Fossey E, Palmer VJ: A scoping review of the use of co-design methods with culturally and linguistically diverse communities to improve or adapt mental health services. Health Soc. Care Community. 2021;29(1):1–17. 10.1111/hsc.13105 [DOI] [PubMed] [Google Scholar]
  • 18. Arch JJ, Mitchell JL, Genung SR, et al. : Randomized trial of acceptance and commitment therapy for anxious cancer survivors in community clinics: Outcomes and moderators. J. Consult. Clin. Psychol. 2021;89(4):327–340. 10.1037/ccp0000630 [DOI] [PubMed] [Google Scholar]
  • 19. Sinclair F, Gillanders D, Rooney N, et al. : Real-world evaluation of an acceptance and commitment therapy-based group programme for breast cancer survivors with fear of cancer recurrence. Support Care Cancer. 2023;31(12):700. 10.1007/s00520-023-08179-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Johns SA, Stutz PV, Talib TL, et al. : Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial. Cancer. 2020;126(1):211–218. 10.1002/cncr.32518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Eldridge SM, Lancaster GA, Campbell MJ, et al. : Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PloS one. 2016;11(3):e0150205. 10.1371/journal.pone.0150205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Coldham T: Guidance on co-producing a research project. NIHR Involve;2018. [Google Scholar]
  • 23. Allan S, Sinclair F, Correia M, et al. : Co-designing a low-intensity psychological therapy for fear of recurrence in psychosis using translational learning from fear of recurrence in oncology: protocol for intervention development for future testing in a feasibility study. BMJ Open. 2024;14(12):e090566. 10.1136/bmjopen-2024-090566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. McMillan SS, King M, Tully MP: How to use the nominal group and Delphi techniques. Int. J. Clin. Pharm. 2016;38(3):655–662. 10.1007/s11096-016-0257-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. McMillan SS, Kelly F, Sav A, et al. : Using the nominal group technique: how to analyse across multiple groups. Health Serv. Outcomes Res. Methodol. 2014;14(3):92–108. 10.1007/s11096-016-0257-x [DOI] [Google Scholar]
  • 26. Kearney N, Connolly D, Bahramian K, et al. : Strategies to improve participation in exercise programmes during chemotherapy: a modified nominal group technique. J. Cancer Surviv. 2025;1–11. 10.1007/s11764-025-01771-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Algeo N, Bennett K, Connolly D: Prioritising the content and delivery of a work-focused intervention for women with breast cancer using the nominal group technique. Work. 2022;73(4):1337–1345. 10.3233/WOR-211160 [DOI] [PubMed] [Google Scholar]
  • 28. Blair C, Rafferty DAM, Murphy P, et al. : Visualising the voices of nursing: a co-designed video capturing the lived experiences of nurses in Northern Ireland during the COVID-19 pandemic. BMC Nurs. 2025;24(1):237. 10.1186/s12912-025-02881-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. AB M: Virtual workshop tools for any team 2026. Reference Source
HRB Open Res. 2026 Oct 19. doi: 10.21956/hrbopenres.16040.r58272

Reviewer response for version 2

Vijaya Prasad Barre 1

This protocol describes the co-design of a group-based psychological intervention for fear of cancer recurrence among young adult cancer survivors in Ireland. The use of the ADAPT framework and involvement of cancer survivors, family caregivers, and healthcare professionals are strengths. The authors should clarify the core components of the existing intervention and identify which aspects will be retained or adapted. Further details on family caregivers and health professionals representation, synthesis of workshop findings, and voting and consensus procedures would strengthen methodological clarity.

Approved with Reservations: The study addresses an important issue in psycho-oncology. Clarification of the intervention adaptation and consensus procedures would strengthen the manuscript without requiring changes to its fundamental design.

Is the study design appropriate for the research question?

Yes

Is the rationale for, and objectives of, the study clearly described?

Yes

Are sufficient details of the methods provided to allow replication by others?

Partly

Are the datasets clearly presented in a useable and accessible format?

Yes

Reviewer Expertise:

Psycho-oncological research

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

HRB Open Res. 2026 Sep 26. doi: 10.21956/hrbopenres.16040.r58140

Reviewer response for version 2

Jan Christopher Cwik 1

This protocol describes the co-design of a group-based fear of cancer recurrence intervention for young adult cancer survivors in Ireland. The proposed combination of three regional workshops and a subsequent online prioritization meeting is well suited to exploring stakeholder preferences for delivery, group composition, and setting.

Involving three PPI partners in protocol development, workshop facilitation, and the steering committee is a strength. Identifying Acceptance and Commitment Therapy as the theoretical foundation, including explicit workshop questions, and distinguishing this development phase from subsequent feasibility testing are also helpful.

My assessment concerns whether the proposed co-design process is sufficiently specified to produce a transparent and usable intervention adaptation. This protocol does not require clinical effectiveness results, a randomized comparison, or a trial-style power calculation. However, the starting intervention, how stakeholder contributions are handled, and the rules linking voting to final design decisions need greater operational clarity.

Major aspects for a potential revision

1. Identify the source intervention and distinguish its core components from the features open to adaptation.

The Introduction now identifies ACT as the theoretical foundation, which addresses part of the earlier reviewer’s question. However, the specific one-to-one intervention remains described primarily by its setting rather than by an identifiable program or treatment specification.

Please identify the intervention’s name, source or manual, current session structure, intended recipients, and principal therapeutic components. If this is a locally developed ACT-informed program rather than a named intervention with its own evaluation, state that explicitly. Distinguish evidence supporting ACT-based approaches more generally from evidence for this particular program.

The objective of maintaining core components is appropriate, but you need to identify those components. A concise table could distinguish the intervention’s therapeutic functions, its current individual-delivery format, and the features that participants may recommend changing.

This matters because the three workshop questions focus mainly on session logistics, group composition, and venue. Please clarify whether this study is deliberately limited to co-designing delivery arrangements around fixed therapeutic content, or whether participants can also influence materials, exercises, language, and the way therapeutic processes operate in a group.

Neither scope is inherently inappropriate. However, changing the number or duration of sessions may affect the content that can be delivered, so the protocol should explain how it will address these interdependencies.

Please also describe what information participants will receive about the existing intervention before making recommendations. Identify the intended output of this phase—for example, a documented delivery specification and adaptation record—and who will check that the proposed format remains consistent with the intervention’s therapeutic rationale. A final adapted manual cannot be expected before co-design, but the process for producing it should be clear.

2. Align stakeholder recruitment with the intended intervention population while preserving appropriate diversity.

The aim specifies patients aged 18–50 years with at least moderate FCR-related distress. Workshop eligibility is broader: survivors may participate if they have experienced FCR or simply have a specific interest in the topic.

Broad participation can be valuable in co-design, and I would not require every contributor to meet a clinical FCR threshold. Nevertheless, the current criteria do not ensure that the people the intervention is intended to serve will be adequately represented.

Please describe how the recruitment process will secure meaningful participation by survivors with relevant FCR experience, including those who have experienced appreciable distress. Clarify whether severity or experience will be characterized through self-report, a brief measure, or another procedure. This information need not function as an exclusion rule.

The proposed six to seven Experts by Experience combine survivors and caregivers. Please specify the intended balance within that group rather than treating their perspectives as interchangeable. Explain whether survivor–caregiver pairs can participate together and how people who qualify under more than one stakeholder category will be counted.

A pragmatic recruitment matrix would help describe the intended diversity across age, cancer experience, time since treatment, geography, and professional background. It need not impose statistically representative quotas.

Several eligibility details also warrant clarification. For survivors, the age criterion appears to refer to current age; for caregivers, it refers to the survivor’s age at treatment completion. Please explain whether this difference is intentional. Justify the study-specific 18–50-year range and the requirement that active treatment ended at least one year previously, and clarify how ongoing maintenance or endocrine treatment will be handled.

Finally, distinguish eligibility for this co-design phase from intended eligibility for the later intervention. Findings from the stated recurrence-free, non-metastatic, English-speaking participant group should not automatically be generalized to all people living with and beyond cancer.

3. Explain how the modified NGT will preserve individual contributions in mixed-status groups.

Dividing each workshop into subgroups of three or four is a reasonable practical response to the planned overall attendance. I do not regard recruiting approximately ten participants per workshop as inherently problematic.

The more important modification is combining idea generation and sharing within mixed groups of survivors, caregivers, and professionals. This could make it difficult to distinguish independently held preferences from suggestions developed after hearing more influential participants.

Please describe the procedures intended to support balanced participation. These might include a brief period of individual written idea generation, structured opportunities for each person to contribute, and an explicit invitation to record disagreement or propose alternatives. An equivalent approach is acceptable; the key is to explain how you will retain less vocal participants’ views.

Please also clarify whether participants may be grouped with their own treating professionals or family members, and how you will manage potential constraints on speaking openly. Mixed groups can facilitate useful exchange, but do not assume they will eliminate differences in authority or confidence.

The PPI co-facilitation role is welcome. Specify the number and roles of facilitators needed for simultaneous subgroups, their preparation, and how you will apply the same procedure across the three locations. Distinguish facilitators’ contributions from participant-generated ideas.

An indicative agenda should show whether the stated 30–40 minutes applies to each question and how clarification, breaks, and whole-group discussion fit within the total workshop duration.

4. Describe how written workshop material will be converted into the final voting options.

The decision not to audio-record the workshops is not itself a methodological flaw. Written outputs may be sufficient for this focused prioritization task. However, the protocol should explain how it will retain enough context to interpret those outputs accurately.

The current description of summative content analysis focuses on identifying recurring keywords and common suggestions. Keyword recurrence alone may not preserve meaning. For example, two notes mentioning virtual delivery could express opposing preferences or identify different conditions under which that format would be acceptable.

Please specify the unit of analysis, who will categorize the material, how ambiguous statements will be clarified, and how similar or overlapping suggestions will be merged. Describe how original notes will remain traceable to the consolidated options presented for voting.

Clarify whether facilitators will document the reasons, qualifications, and disagreements expressed during the final discussion. Where no such record is planned, acknowledge that the analysis concerns the written suggestions rather than a comprehensive account of the discussion.

Also distinguish how often an idea appears on Post-it notes from how many individual participants support it. A jointly produced subgroup note does not necessarily represent agreement by every subgroup member.

Please explain whether all distinct suggestions will reach the voting stage or whether some will be screened out beforehand. Any screening criteria should be transparent and should not automatically remove an accessibility concern merely because it was mentioned infrequently.

Finally, describe how participants, including the PPI partners, will be able to check that the consolidated options accurately represent the original contributions before voting begins.

5. Specify the voting procedure, the meaning of consensus, and the authority for final decisions.

The statement that participants will rank each idea from 1 to 5 is ambiguous. Please clarify whether participants will independently rate every option on a five-point scale, select and rank their five preferred options, or use another procedure. State how unselected options, ties, incomplete ballots, and abstentions will be handled.

The protocol should then explain the decision rule. Adding votes or points provides a prioritization result, but readers still need to know what qualifies a proposed feature for inclusion in the adapted program and what the authors mean by consensus.

A numerical agreement threshold is not mandatory for every NGT study. However, include a transparent rule for interpreting the results, resolving tied or incompatible preferences, and documenting disagreement. If the intended output is a ranked set of stakeholder priorities rather than a formally agreed consensus, describe it accordingly.

Please consider reporting both the strength of preference and the breadth of support where relevant to the chosen voting system. The analysis across multiple groups discussed in the manuscript’s reference 25 is particularly relevant to this distinction.

All regional workshop participants will be invited to the final online meeting, but not all may attend. Specify the minimum participation or stakeholder coverage considered sufficient, how differential attendance will be described, and whether an equivalent voting opportunity will be available to those unable to join synchronously. Any alternative route should use the same information and avoid duplicate voting.

Clarify whether votes will be confidential and whether aggregate results will be displayed only after the initial ballot has closed. The current reference to real-time results does not establish this sequence.

Finally, explain how the voting results will interact with the steering committee’s clinical and practical judgments. Who has final decision-making authority? How will recommendations that conflict with therapeutic requirements or available resources be handled? Documenting these decisions, their reasons, and PPI involvement is preferable to presenting every final design feature as a direct product of consensus.

6. Add proportionate safeguards and a data-management plan for the co-design activities.

Ethical approval and the intention to obtain written consent are reported. Nevertheless, the protocol should briefly describe the practical safeguards for discussing potentially distressing cancer experiences in mixed groups.

Please state how participants can pause, decline a discussion topic, or leave a workshop, and what support or referral arrangements will be available if participation becomes distressing. Distinguish the co-design activity from psychological treatment so that expectations are clear.

Explain the confidentiality arrangements for group discussions, including the limits of what researchers can guarantee concerning information heard by other participants. The consent materials should also describe how withdrawal will operate once individual suggestions have been incorporated into group outputs.

For the written notes, demographic information, and Mentimeter responses, identify what will be retained, whether responses will be identifiable, who will have access, and how data will be stored securely. Clarify the information that will be entered into the third-party voting platform and how the resulting dataset will be exported and managed.

The statement that no underlying data accompany a protocol is appropriate. It would nevertheless be useful to describe which non-identifying materials and outputs will subsequently be made available, such as workshop guides, the coding framework, aggregated voting results, and the adaptation record.

Minor aspects for a potential revision

1. Report study status and distinguish planned procedures from completed activities.

Ethical approval is dated May 2025, and Table 1 describes the prevalence survey and scoping review as completed. Please provide the recruitment/workshop timetable and indicate which activities had begun or been completed when you prepared this protocol version.

This is especially relevant to the voting and synthesis rules: readers should be able to distinguish procedures specified before data collection from amendments introduced later. If workshops have already occurred, report that transparently rather than retrospectively describing new procedures as prespecified.

A brief indication of where dated protocol amendments will be documented would be sufficient.

2. Clarify access arrangements and moderate claims of national representation.

Holding workshops in three regions can broaden geographical participation, but it does not by itself ensure national representativeness. Describe the intended regional coverage and use language such as geographically diverse participation unless stronger representativeness claims can be supported.

Please state whether travel expenses, reimbursement for participants’ time, accessible venues, flexible scheduling, or technical support for the online meeting are available. These practical details are directly relevant to a project concerned with accessible intervention design.

Where participants cannot attend in person or use the online platform, describe any available accommodation and acknowledge the remaining limits of recruitment through the stated channels.

3. Correct the source attribution and presentation issues.

The statement that a local feasibility study indicated interest in group delivery cites reference 21, which is a methodological paper defining feasibility and pilot studies rather than a report of that local work. Please cite the relevant study or identify the finding as unpublished local work, with enough information to understand its basis. Clarify its relationship, if any, to the 394-person survey in Table 1.

The planned GRIPP2-SF reporting is appropriate, but reference 16 is a meta-epidemiological evaluation of PPI reporting. Please also cite the original GRIPP2 reporting checklist publication.

The Discussion refers to adapting an existing group-based intervention, whereas the rest of the protocol describes adapting a one-to-one intervention into groups. Please correct this distinction. In Table 1, align the explanation that Step 4 is not applicable because this is a feasibility pilot with the current co-design phase and the wider project.

Move the planned data analysis out of the otherwise empty Results heading. Describe NGT as a structured consensus or prioritization method rather than a therapeutic group intervention.

4. Keep the claims proportionate to what co-design can establish.

The rationale for potential peer support, accessibility, and resource efficiency is understandable. However, these should remain anticipated advantages to be evaluated, not benefits established by this protocol.

Similarly, stakeholder judgments about the “most effective” way to deliver the program concern perceived suitability and preferences, not comparative clinical effectiveness. Consider wording the first workshop question around acceptable and workable delivery arrangements while retaining space for participants to explain their reasoning.

Keep the distinction between this phase and the later feasibility pilot explicit throughout. Co-design can produce a stakeholder-informed adaptation; feasibility, sustained engagement, clinical benefit, and resource efficiency require subsequent evaluation.

Is the study design appropriate for the research question?

Yes

Is the rationale for, and objectives of, the study clearly described?

Yes

Are sufficient details of the methods provided to allow replication by others?

Partly

Are the datasets clearly presented in a useable and accessible format?

Yes

Reviewer Expertise:

Psycho-oncology; Psychotherapy; Clinical Psychology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

HRB Open Res. 2026 Oct 10.
Catherine O'Brien 1

We are grateful to the reviewer for their detailed and constructive feedback. A number of revisions have been made to improve clarity and methodological transparency. While several suggestions would undoubtedly strengthen the reporting of the completed study, we considered some of the requested detail to extend beyond the purpose of a protocol manuscript, as many of these decisions and outputs will emerge through the co-design process itself. We have therefore sought to provide sufficient methodological detail while maintaining the flexibility necessary for meaningful stakeholder engagement.

Comment 1: Source intervention and intervention components

We thank the reviewer for this helpful suggestion. The manuscript has been revised to provide additional information on the existing intervention, including its ACT-informed theoretical foundation and key CBT components. As this manuscript presents a protocol, our intention is to outline the intervention sufficiently to contextualise the proposed co-design process, while recognising that a detailed intervention specification will be developed and reported following completion of the co-design phase.

Comment 2: Stakeholder recruitment and representation

We appreciate the reviewer's thoughtful comments regarding participant representation. Clarifications have been added regarding eligibility criteria and stakeholder groups. Given the aims of the co-design process, a purposive approach will be used to ensure a range of perspectives is represented. While we acknowledge the value of a more detailed recruitment framework, we considered this level of specification beyond the scope of the current protocol.

Comment 3: Modified NGT process

We thank the reviewer for highlighting the importance of ensuring equitable participation across stakeholder groups. Additional detail has been provided regarding workshop facilitation and the planned modified nominal group technique. As the protocol describes a flexible co-design process, some procedural elements will necessarily be refined in response to participant engagement and workshop discussions.

Comment 4: Development of voting options

We appreciate this suggestion. Given that the recommendations will be generated through the co-design process itself, the precise procedures for categorisation and refinement will be reported in the findings arising from the completed study rather than within the protocol.

Comment 5: Consensus and voting procedures

We thank the reviewer for this observation. The purpose of the voting exercise is to identify stakeholder priorities and guide adaptation decisions rather than to achieve formal consensus. We have therefore outlined the planned prioritisation process while retaining flexibility for decisions that will be informed by participant contributions during the workshops.

Comment 6: Safeguards and data management

We appreciate the reviewer's attention to participant welfare and study governance. Ethical oversight, consent procedures, and data management processes are described within the protocol. More detailed operational procedures will be implemented in accordance with institutional and ethical requirements and were considered outside the intended scope of this protocol manuscript.

Minor Comment 1: Study status

We thank the reviewer for this helpful recommendation. Additional clarification has been included to distinguish the current protocol from the broader programme of work and to clearly outline the focus of the present study.

Minor Comment 2: Representativeness and accessibility

We appreciate this comment and have revised the wording to avoid implying national representativeness. Consistent with co-design methodology, the aim is to engage a range of relevant perspectives rather than achieve a representative sample.

Minor Comment 3: Presentation and clarity

We thank the reviewer for these observations. The manuscript has been reviewed and amended where appropriate to enhance clarity and consistency.

Minor Comment 4: Strength of claims

We appreciate this observation and have reviewed and amended where appropriate to ensure the claims remain proportionate to the aims of the proposed co-design study. The effectiveness of the adapted intervention will be explored in future phases of research.

HRB Open Res. 2026 Aug 12. doi: 10.21956/hrbopenres.15918.r57181

Reviewer response for version 1

Johanne D Lyhne 1

Great and important study, and lovely to see you prioritizing this important step.  

Comments: 

Please state if it is a specific intervention you aim to adapt - "an existing one-to-one FCR psychological intervention". Can we get more information? Is it an evidence-based intervention? How many session? What theoretical content? 

Please state if you aim for an equal distribution between experts by experience and experts by profession in the workshops. 

Please state if you will be selective/inclusive regarding cancer type. Will you aim for a broad representation of diagnoses? 

Please state if you will be selective/inclusive regarding professions. Will you aim for a broad representations of clinical staff? 

Consider the possibility to include experts by experience who are also experienced with FCR. If you design an intervention for survivors with at least moderate FCR, consider use this as an inclusion criteria for this process as well. 

Do you have any considerations regarding virtual delivery? 

Good luck!

Is the study design appropriate for the research question?

Yes

Is the rationale for, and objectives of, the study clearly described?

Yes

Are sufficient details of the methods provided to allow replication by others?

Partly

Are the datasets clearly presented in a useable and accessible format?

Not applicable

Reviewer Expertise:

Psycho-oncology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Availability Statement

    Underlying data

    No data are associated with this article.


    Articles from HRB Open Research are provided here courtesy of Health Research Board Ireland

    RESOURCES